Epi Biotech Co (XKRX:446440) Receivables Turnover : 0.00 (As of . 20)

View and export this data going back to 2023. Start your Free Trial

What is Epi Biotech Co Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Epi Biotech Co's Revenue for the six months ended in . 20 was ₩0.00 Mil. Epi Biotech Co's average Accounts Receivable for the six months ended in . 20 was ₩0.00 Mil.

Epi Biotech Co Receivables Turnover Historical Data

The historical data trend for Epi Biotech Co's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Epi Biotech Co Receivables Turnover Chart

Epi Biotech Co Annual Data

Trend

Receivables Turnover

Epi Biotech Co Semi-Annual Data

Receivables Turnover

Competitive Comparison of Epi Biotech Co's Receivables Turnover

For the Biotechnology subindustry, Epi Biotech Co's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Epi Biotech Co's Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Epi Biotech Co's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Epi Biotech Co's Receivables Turnover falls into.

Save Embed

;

Save Embed

;

Epi Biotech Co Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Epi Biotech Co's Receivables Turnover for the fiscal year that ended in . 20 is calculated as

	Receivables Turnover (A: . 20 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: . 20 )	/ (	(Accounts Receivable (A: . 20 )	+	Accounts Receivable (A: . 20 ))	/	count )
=		/ (	(	+	)	/	1 )
=		/	0
=	N/A

Epi Biotech Co's Receivables Turnover for the quarter that ended in . 20 is calculated as

	Receivables Turnover (Q: . 20 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: . 20 )	/ (	(Accounts Receivable (Q: . 20 )	+	Accounts Receivable (Q: . 20 ))	/	count )
=		/ (	(	+	)	/	1 )
=		/	0
=	N/A

Epi Biotech Co (XKRX:446440) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Epi Biotech Co Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Epi Biotech Co's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Epi Biotech Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Epi Biotech Co Ltd (XKRX:446440) » Definitions » Receivables Turnover

Comparable Companies

Traded in Other Exchanges

N/A

Address

32, Songdogwahak-ro, Rooms 1903 and 1904, 15th floor, M-dong, Yeonsu-gu, Incheon, KOR, 21984

Website

http://www.epibiotech.com

Epi Biotech Co Ltd is developing various pipelines for each hair loss treatment modality. It also conducts R&D in skin regeneration treatments to create commercially viable consumer products. The company specializes in hair loss treatment in Korea.

Epi Biotech Co Headlines

No Headlines